Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2010/091/001048
CTRI/2010/091/001048
Recruiting
Phase 1

se of Autologous bone marrow stem cell transplantation therapy in the treatment of Chronic Renal Failure in 5 indian patients. ABMST-CRF Study (Autologous Bone marrow Stem cell Transplantation-CRF).

International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 5600640 sites5 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 560064
Enrollment
5
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 560064

Eligibility Criteria

Inclusion Criteria

  • •1\. Must be able to give voluntary written (patients may not be able to write) consent.
  • •2\. Must be able to understand study information provided to him.
  • •3\. CKD patients of stage IV and ESRD with age 18 to 65 years.
  • •4\. Patient should be afebrile 24 hours prior to procedure.

Exclusion Criteria

  • •1\.Women who are pregnant or lactating
  • •2\.Acute Renal Failure
  • •3\.Severe co\-morbidities like cardiac insufficiency, congestive cardicac failure, malignancy, infection, sepsis and bed sores.
  • •4\.Haemoglobin level below 8g %
  • •5\.Chronic kidney disease due to autoimmune aetiology, connective tissue disease, amyloidosis and storage disorders.
  • •6\.Known bleeding or coagulation disorder
  • •7\.Known hematologic disease
  • •8\.Poorly controlled hypertension
  • •9\.Evidence of active malignancy within one year prior to randomization.
  • •10\.Severe skin infection or osteomyelitis \- the site of bone marrow aspiration potentially limiting the procedure.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Bone marrow stem cell transplantation in patients with decompensated liver cirrhosisDecompensated liver cirrhosisDigestive SystemChronic Liver Disease/Cirrhosis
ISRCTN16139487. Kipshidze Central University Hospital (Georgia)34
Recruiting
Phase 1
Safety and efficacy of autologous stem cells derived from bone marrow in treating Osteoarthritis
CTRI/2010/091/001044International Stemcell Services Limited117, Venkateshwara Nagar, Jakkur, Bengaluru 56006410
Completed
Not Applicable
Autologous bone marrow cells in patients with critical limb ischemia
ISRCTN16096154ational Institute of Heart and Vascular Diseases62
Completed
Not Applicable
Selected autologous bone marrow cell transplant following trans-mural myocardial infarction in patients undergoing coronary surgery: A prospective, double-blind, randomised controlled trial
ISRCTN65630838nited Bristol Healthcare NHS Trust (UK)60
Completed
Phase 2
Treatment of cirrhotic of liverCirrhotic of liver.Chronic passive congestion of liver
IRCT2014091919217N1Vice chancellor for research, Mashhad University of Medical Sciences20